4//SEC Filing
Casciano Anthony 4
Accession 0001104659-19-020171
CIK 0000792977other
Filed
Apr 4, 8:00 PM ET
Accepted
Apr 5, 4:10 PM ET
Size
7.7 KB
Accession
0001104659-19-020171
Insider Transaction Report
Form 4
Casciano Anthony
Chief Commercial Officer
Transactions
- Award
Common Stock
2019-04-04+15,000→ 60,852 total - Award
Stock Option (Right to Buy)
2019-04-04+25,000→ 25,000 totalExercise: $13.03Exp: 2029-04-04→ Common Stock (25,000 underlying)
Footnotes (4)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of Common Stock of AMAG Pharmaceuticals, Inc. (the "Issuer").
- [F2]These shares of Common Stock are issuable pursuant to a grant of RSUs pursuant to the Issuer's Fourth Amended & Restated 2007 Equity Incentive Plan, as amended (the "Plan") that will vest in three equal annual installments with the first installment vesting on April 4, 2020.
- [F3]Not applicable.
- [F4]Grant of stock option pursuant to the Plan. This option will vest and become exercisable over four years after the grant date as follows: (i) 25% on the first anniversary of the grant date and (ii) the balance vesting in equal quarterly installments over the next three years thereafter.
Documents
Issuer
AMAG PHARMACEUTICALS INC.
CIK 0000792977
Entity typeother
Related Parties
1- filerCIK 0001772630
Filing Metadata
- Form type
- 4
- Filed
- Apr 4, 8:00 PM ET
- Accepted
- Apr 5, 4:10 PM ET
- Size
- 7.7 KB